CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Eli Lilly and Company Company Snapshot
Eli Lilly and Company operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other companies in this sector in the United States: Teva Pharmaceutical Industries Limited (2017 sales of $22.39 billion of which 55% was Generic Medicines), Bristol-Myers Squibb Company ($20.78 billion of which 100% was Pharmaceuticals), and AstraZeneca PLC ($22.47 billion of which 100% was Pharmaceuticals).

Sales Analysis. Eli Lilly and Company reported sales of $22.87 billion for the year ending December of 2017. This represents an increase of 7.8% versus 2016, when the company's sales were $21.22 billion. This was the third consecutive year of growth at Eli Lilly and Company. The sales level in 2017 was fairly close to the level five years ago: in 2012, Eli Lilly and Company had sales of $22.60 billion. Sales of Human Pharmaceutical Products - Endocrin saw an increase that was more than double the company's growth rate: sales were up 24.8% in 2017, from $8.08 billion to $10.09 billion. Not all segments of Eli Lilly and Company experienced an increase in sales in 2017: sales of Other Pharmaceuticals fell 23.1% to $241.30 million. (However, this segment's sales were only a very small portion of the company's overall sales). Eli Lilly and Company also experienced decreases in sales in Animal Health (down 2.3% to $3.09 billion) and Human Pharmaceutical Products - Cardiova (down 11.0% to $2.87 billion) and Human Pharmaceutical Products -Neuroscie (down 20.2% to $2.17 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Eli Lilly and Company
  Stock Performance Chart for Eli Lilly and Company
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 102.25
(Figures in U.S. Dollars)
1 Week 1.7%   13 Weeks 14.0%  
4 Weeks 24.0%   52 Weeks 26.0%  
 
Eli Lilly and Company Key Data:
  Ticker: LLY Country: United States
  Exchanges: NYSE FRA LON MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 22,871,300,000
(Year Ending Jan 2018).
Employees: 40,655
  Currency: U.S. Dollars Market Cap: 110,985,260,445
  Fiscal Yr Ends: December Shares Outstanding: 1,085,430,420
  Share Type: Common Closely Held Shares: 2,142,716
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.